Some thoughts on use of randomized controlled in individual patients in TCM researches

Abstract

Abstract: This paperdescribed the design model of randomized controlled trial in individual patients(N of 1 RCTs)and the conditions of conducting this study de-sign,and also pointed out the key points to be considered in conducting an N of 1 RCTs in clinical trial of TCM,i.e.the implementation of blindness,selection of the con-trolled drug and effect indices,setting uPof wash-out pe-riod and the generalization of the study findings.

Key words: randomized controlled trial, clinical tri-al, traditional Chinese medicine, individualized treatment

CLC Number:

R969

XU Wei-hua. Some thoughts on use of randomized controlled in individual patients in TCM researches[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(11): 1315-1317.

References

1 Guyatt G,Sackett D,TaylorDW,Chong J,Roberts R,Pugsley S.Determining optimal therapy-randomized trials in individual patients[J].N Engl JMed,1986;314:889-92
2 Guyatt G,Sackett D,Adachi J,Roberts R,Chong J,Rosen-bloom D,et al.A clinician' s guide forconduction randomized trials in individual patients[J].CAMJ,1988;139:497-503
3 赖世隆.临床医学研究设计概要[A].见:赖世隆,主编.中西医结合临床科研方法学[M].第 1 版.北京:科学出版社,2003:63
4 McLeod RS,TaylorDW,Cohen Z,Cullen JB.Single-patient ran-domised clinical trial.Use in determining optimum treatment forpatient with inflammation of Kock continent ileostomy reservoir[J].Lancet,1986;1:726-8
5 Mahon J,Laupacis A,DonnerA,Wood T.Randomized study of n of 1 trials versus standard practice[J].BMJ,1996;312:1069-74
6 March L,Irwig L,Schwarz J,Simpson J,Chock C,Brooks P.N of 1 Trials Comparing a Non-Steroidal Anti -Inflammatory Drug with Paracetamol inOsteoarthritis[J].BMJ,1994;309:1041-45
7 ChatellierG,Day M,Bobrie G,Menard J.Feasibility Study of N-of -1 TrialsWith Blood Pressure Self-Monitoring in Hypertension[J].Hypertension,1995;25:294-301
8 Guyatt GH,KellerJL,Jaeschke R,Rosenbloom D,Adachi JD,Newhouse MT.The n-of -1 randomized controlled trial:clinical usefulness.Ourthree-yearexperience[J].Annals of Internal Medicine,1990;112:293-9
9 Johannessen T.Controlled trials in single subjects.I.Value in clinical medicine[J].BMJ,1991;303:173-4
10 Miquel P,Francisco B,Ildefonso H,Jesus V.N of 1 trials:Research isneededinto why such trials are not more widely used[J].BMJ,1996,313:427
11 Saunders KB.Could it be that editorially you have somewhat exaggerated the point[J] ?BMJ,1994;309:1584
12 Lewis JA.Controlled trials in single subjects.II.Limitationsof use[J].BMJ,1991;303:175-6
13 Guyatt GH,Heyting A,Jaeschke R,KellerJ,Adachi JD,Roberts RS.Controlled clinical trials[J].1990;11:88-100
14 Brad J,Edward M.N-of-1 randomized controlled trials in com-plementary and alternative medicine[R].http: www.camerar-esearchnetwork.ab.ca research 2004abs6.html

[1]	HU Kangyi, CAO Linzhong, WAN Chaochao, SHANG Zhengya, YANG Xiaorui, ZHANG Yongjie. Research progress of traditional Chinese medicine regulating mitochondrial function in the treatment of steroid-induced femoral head necrosis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 688-696.
[2]	QIN Wenxiu, XU Junfeng, YANG Ting, WANG Pingfei. Research progress on signaling pathway of tanshinoneIIA in treatment of nerve injury after ischemic stroke [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 705-713.
[3]	LI Yanyang, WANG Yunjiao, LV Shichao. Effects and mechanism of traditional Chinese medicine injection in prevention and treatment of cardiotoxicity induced by antineoplastic drugs [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 572-577.
[4]	LI Shuang, HAN Shuzhen, DAI Yuting, XIU Minghui, DU Xianqin, HE Jianzheng, LIN Xingyao. Progress in the prevention and treatment of traditional Chinese medicine based on the mechanism of intestinal injury of various chemotherapy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 583-593.
[5]	QI Xiaofeng, LUO Yali, XIAO Mengyong, ZHOU Shiqin, ZHOU Wen, AN Fangyu, WEI Benjun, LIU Yongqi. Research status of dialectical prevention and treatment of acute lung injury based on the theory of "Wei qi and Ying Xue" [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 429-437.
[6]	CHEN Shengfu, LI Xiaolin, WANG Weigang, DU Weize, LI Maoxing. Research progress on antipyretic effect of Chinese medicine [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 334-344.
[7]	WANG Wenjuan, QI Mingrui, TIAN Limin. Research progress on Nrf2 in diabetic cardiomyopathy and intervention of traditional Chinese medicine [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1163-1170.
[8]	CHEN Ying, YUAN Yonggui. Research progress in the treatment of depression with monome of Chinese herb, drug pairs, compound prescriptions and Chinese patent drugs [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 586-593.
[9]	YIN Yujie, CHANG Liping. Pharmacological research and clinical applications progress of Lianhua Qingwen capsules/granules in respiratory diseases [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(10): 1174-1180.
[10]	MU Xin, ZHAO Ying, ZHANG Lan, CUI Yimin, ZHANG Yongxiang, DU Guanhua. Drug clinical trial of COVID-19 in China: A brief analysis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(8): 869-877.
[11]	FENG Rui, ZHANG Jiali, HE Mingchao, LI Yue, ZHANG Yan. Pharmacological targets and clinical application of traditional Chinese medicine and active components in the prevention and treatment for depression [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 467-474.
[12]	LU Yubao, CHEN Yutong, HE Gege, CAI Zongyan, CHENG Yue, CHENG Zihua, GUO Jiamin, GUO Yanzhi. Application of traditional Chinese medicine extract in repairing spinal cord injury [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(9): 1075-1080.
[13]	FAN Qilin，ZHENG Xiao，WANG Shumei，HAO Haiping，LI Ping. Abnormal regulation of autophagy in inflammatory bowel disease and the intervention of traditional Chinese medicine [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(4): 471-480.
[14]	SHEN Bin，JIANG Liya，WANG Xiaoling，XU Longsheng，LU Xiaolei，HE Jiayang，SUN Peiyu，ZHOU Yuehong，ZHANG Xiaoping. Study and rationality evaluation on off-label drug use of traditional Chinese medicine injection [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(2): 223-227.
[15]	LIU Yaqi, LU Mengjie, LIU Yuxiu, CHEN Yu, YUAN Yangdan, ZHOU Chongchong, LIU Man. Blinded analysis of double-blind randomized controlled trial for unequal integer ratio grouping [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(10): 1155-1160.